- Home
- ITCI vs ZTO Comparison
ITCI vs ZTO Comparison
Compare ITCI & ZTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- ZTO
- Stock Information
- Founded
- ITCI 2002
- ZTO 2002
- Country
- ITCI United States
- ZTO China
- Employees
- ITCI N/A
- ZTO N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- ZTO Advertising
- Sector
- ITCI Health Care
- ZTO Consumer Discretionary
- Exchange
- ITCI Nasdaq
- ZTO Nasdaq
- Market Cap
- ITCI 13.5B
- ZTO 15.0B
- IPO Year
- ITCI N/A
- ZTO 2016
- Fundamental
- Price
- ITCI $131.36
- ZTO $19.40
- Analyst Decision
- ITCI Buy
- ZTO Buy
- Analyst Count
- ITCI 13
- ZTO 4
- Target Price
- ITCI $106.58
- ZTO $26.38
- AVG Volume (30 Days)
- ITCI 2.2M
- ZTO 2.4M
- Earning Date
- ITCI 05-06-2025
- ZTO 03-18-2025
- Dividend Yield
- ITCI N/A
- ZTO 5.00%
- EPS Growth
- ITCI N/A
- ZTO N/A
- EPS
- ITCI N/A
- ZTO 1.49
- Revenue
- ITCI $680,852,000.00
- ZTO $5,984,810,313.00
- Revenue This Year
- ITCI $40.64
- ZTO $14.32
- Revenue Next Year
- ITCI $58.53
- ZTO $10.13
- P/E Ratio
- ITCI N/A
- ZTO $12.87
- Revenue Growth
- ITCI 46.62
- ZTO 11.44
- 52 Week Low
- ITCI $63.30
- ZTO $17.89
- 52 Week High
- ITCI $131.37
- ZTO $27.50
- Technical
- Relative Strength Index (RSI)
- ITCI 85.33
- ZTO 46.25
- Support Level
- ITCI $131.19
- ZTO $19.25
- Resistance Level
- ITCI $131.37
- ZTO $20.59
- Average True Range (ATR)
- ITCI 0.26
- ZTO 0.53
- MACD
- ITCI -0.55
- ZTO -0.11
- Stochastic Oscillator
- ITCI 99.70
- ZTO 17.60
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 22.1% in 2022. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 77% voting rights as of June 30, 2023. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 11.7% interest.